# Nuclide record paper-herrmann-radiotheranostics-lancet-oncol-2020 (paper). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/key-papers/paper-herrmann-radiotheranostics-lancet-oncol-2020/>
  a schema:ScholarlyArticle ;
  nuclide:kind "paper" ;
  schema:identifier "paper-herrmann-radiotheranostics-lancet-oncol-2020" ;
  schema:name "Radiotheranostics: a roadmap for future development"@en ;
  schema:description "A group of leading nuclear medicine specialists set out, in one article, what needs to happen - in science, manufacturing, regulation and training - for more radioactive scan-and-treat drugs to reach patients over the following five years."@en ;
  schema:url <https://nuclide.cc/key-papers/paper-herrmann-radiotheranostics-lancet-oncol-2020/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30821-6/abstract>, <https://pubmed.ncbi.nlm.nih.gov/32135118/> ;
  nuclide:tag "review", "roadmap", "theranostics" ;
  schema:sameAs <https://doi.org/10.1016/S1470-2045(19)30821-6> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Herrmann K, Schwaiger M, Lewis JS, Solomon SB, McNeil BJ, et al." ;
  nuclide:related <https://nuclide.cc/terms/theranostics/>, <https://nuclide.cc/technologies/therapy-isotope-supply-chain/>, <https://nuclide.cc/technologies/radiopharmaceutical-gmp-release/>, <https://nuclide.cc/technologies/radiopharmacy-network/>, <https://nuclide.cc/people/ken-herrmann/>, <https://nuclide.cc/people/jason-lewis/>, <https://nuclide.cc/isotopes/lu-177/> .